
Capza 5 Flex Equity holds €450m first closing
French private equity specialist Capza has held a first close for Capza 5 Flex Equity on €450m.
The vehicle has a target of €500m and has already exceeded the size of its predecessor, which closed on €350m in October 2016.
With this new closing, Capza has reached €4bn in assets under management.
Investors
This fund raised capital from Capza's historical investors, which include family offices, insurers, funds-of-funds, public institutions and pension funds, as well as new French and international investors.
"We welcome our investors' renewed trust in this new fund. It confirms the relevance of our investment strategy, which emphasises diversification and focuses on resilient sectors across Europe," said Benoit Choppin, co-head of Flex Equity France at Capza.
Investments
The fund will provide flexible financing that combines majority or minority capital, convertible bonds and mezzanine. It will offer tailor-made equity packages adapted to the company's project.
The vehicle aims to support mid-cap companies in France, Spain, Germany and Italy with turnovers of up to €150m in their development and expansion projects.
Like its predecessor, the new fund plans to complete 20-25 investments over a five-year investment period. Around 70-75% of the capital should be deployed as mezzanine, with the remainder invested as equity.
"This hybrid model enables us to be especially agile and to invest in capital and mezzanine at a time when financing is likely to be more constrained and when entrepreneurs will need our support more than ever," said Maxence Radix, co-head of Flex Equity France at Capza.
Latest News
LP Profile: IMCO
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018